January 12, 2026

Spinal Cord Injury Tied to Chronic Disease Risk

Traumatic spinal cord injury may carry significant long-term cardiovascular, neurologic, psychiatric, and endocrine risks.

Conexiant

January 09, 2026

AAN Issues Guideline on Functional Seizures

Psychological interventions nearly double the odds of seizure freedom; benzodiazepines and antiseizure medications not recommended without co-occurring epilepsy

Conexiant

January 08, 2026

Lupus Disease Activity Linked to Incontinence

Urinary incontinence affects quality of life in patients with systemic lupus erythematosus and may warrant routine assessment in clinical practice.

Conexiant

January 08, 2026

Optoretinography: The Next Frontier in Photoreceptor Analysis? 

New TVST study reviews optoretinography as emerging noninvasive technique for measuring photoreceptor function

The Ophthalmologist

January 08, 2026

One Night's Sleep May Predict 130 Diseases

Foundation model trained on more than half a million hours of polysomnography data outperforms demographic baselines in forecasting mortality, dementia, and cardiovascular outcomes

Conexiant

January 05, 2026

Do Statins Benefit Low-Risk Type 2 Diabetes?

Researchers evaluated statin benefits across cardiovascular risk levels in type 2 diabetes.

Conexiant

January 02, 2026

NK-1 Drug Fills Motion Sickness Gap

Tradipitant demonstrates 50% to 70% risk reduction for vomiting incidence during motion exposure in phase 3 trials.

Conexiant

December 29, 2025

Medical Oddities: Dairy and Dementia’s New Angle

From cheese counters to tea kettles to rush hour—and even the role of romance—new studies suggest health shows up in unexpected places.

Conexiant

December 22, 2025

Long-Term Tofersen Shows Benefit in SOD1-Mutated ALS

Final data from the phase III VALOR trial and its open-label extension study showed that patients with SOD1-mutated ALS benefit from treatment with the intrathecal antisense oligonucleotide tofersen.

Conexiant